查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
失禁設備和造口術市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273524

失禁設備和造口術市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Incontinence Devices and Ostomy Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，失禁和造口護理產品市場預計將以近 10.1% 的複合年增長率增長。

COVID-19 大流行的爆發對失禁設備和造口術業務產生了重大影響，僅進行了自爆發以來最嚴重的造口手術。 造口護理是一個經常被忽視的方面，在大流行期間沒有發布具體的造口護理建議。 根據國家醫學圖書館 2022 年 3 月發表的一項研究，造口數量在 2020 年 3 月至 2021 年 2 月期間減少了 19.5%。 因此，造口相關手術的減少阻礙了大流行期間的市場增長。 然而，由於大多數患者選擇了家庭護理，同期家庭護理對造口護理產品的需求顯著增加。 因此，COVID-19 對市場增長產生了重大影響。 然而，隨著 COVID-19 病例的消退，市場已經恢復得很好，預計在預測期內將保持同樣的趨勢。

促成研究市場增長的主要因素是炎症性腸病 (IBD) 的高患病率、潰瘍性結腸炎和克羅恩病等尿失禁 (UI) 患病率的上升，以及造口手術病例的增加由於結直腸癌。 根據世界衛生組織 2021 年 7 月的更新，到 2030 年，全球結直腸癌病例預計將增加約 70%。 此外，根據 GLOBOCAN 公佈的統計數據，結直腸癌 (CRC) 是德國人口中第四大最常見的癌症，2021 年德國報告了大約 57,528 例新的 CRC 病例。我是。 此外，根據 GLOBOCAN 提供的統計數據，2020 年英國報告了約 33,815 例結腸癌新病例和 11,951 例新死亡病例，增加了對造口手術和設備的需求，推動了預測期內的市場增長。我們支持增長。 此外，根據 Female Pelvic Medicine & Reconstructive Surgery 於 2022 年 4 月發表的一項研究，61.8% 的女性患有尿失禁 (UI)，相當於美國有 78,297,094 名成年女性，到 2021 年，至少有 32.4% 的所有報告症狀每月。 在 UI 患者中，37.5% 被發現有壓力性尿失禁，22.0% 有急迫性尿失禁，31.3% 有混合症狀，9.2% 有不明原因尿失禁。 因此，預計女性 UI 的高負擔將增加對失禁產品的需求，這有望在預測期內推動市場增長。

有助於改善造口術患者生活質量的高效、合適的造口袋系統及相關配件的開發有望在預測期內為所研究的市場開闢增長前景。 例如，Trio Healthcare 推出了一種矽基造口術密封件 Triosiltac。 該產品有助於防止滲漏並保護造口周圍的皮膚。 預計此類技術進步將在預測期內推動市場增長。

此外，越來越多的努力提高個人對造口術的認識，進一步推動了市場的增長。 例如，美國聯合造口術協會 (UOAA) 致力於提高造口術醫療保健的質量，並在所有醫療保健機構中提高護理標準。 該組織在每年 10 月的第一個星期六舉辦“世界造口日”，以提高人們對造口護理的認識。 這些努力有望提高公眾對造口護理的認識並促進市場增長。

但是，缺乏足夠的報銷以及與使用造口術和失禁產品相關的並發症可能會限制市場增長。

失禁器械和造口術市場趨勢

結腸造口袋有望在應用領域增長良好

結腸造口袋，也稱為造口袋或造口袋，是一種用於收集身體排洩物的小型防水袋。 一種稱為結腸造口術的外科手術會在大腸和腹壁之間創建一個稱為造口或造口術的開口。 這使得廢物可以通過腹壁的開口而不是通過大腸、直腸和肛門排出體外。 糞便和其他廢物被排入一個囊狀的結腸造口袋中，可以定期清空。

由於炎症性腸病 (IBD) 的興起，對這種袋子的需求逐年增加。 例如，根據 2021 年 8 月發表在 BMC Journal 上的一項研究，在英國，2021 年炎症性腸病（IBD）、克羅恩病（CD）和潰瘍性結腸炎（UC）的發病率將是每 100,000 人分別有 28.6、10.2 和 15.7 人。 這些疾病的高發病率預計將推動市場增長。

此外，越來越多的產品發布預計也將在未來幾年進一步推動該細分市場的增長。 引入高效和合適的造口袋有助於改善造口術患者的生活質量，預計將為該細分市場的增長提供充足的增長機會。 例如，2021 年 6 月，卡迪夫的 Pelican Healthcare Ltd 推出了 ModaViostomy 袋系列，鞏固了其作為英國和愛爾蘭醫療保健領域一次性造口設備領先製造商之一的地位。

失禁器械和造口術市場-IMG1

北美主導市場，預計在預測期內也會如此

北美在失禁和造口護理產品市場佔據主導地位，收入份額最大，原因是克羅恩病和潰瘍性結腸炎患者數量不斷增加，造口護理和造口手術意識不斷增強等因素。 .

根據 2023 年約翰霍普金斯大學的一篇論文，超過 2500 萬成年美國人患有暫時性或慢性尿失禁。 此外，僅在美國，治療 UI 的費用就達 163 億美元，其中 75% 用於治療女性。 因此，美國尿失禁的患病率正在增加，預計這將推動市場增長。

此外，一些市場參與者正在實施各種戰略舉措來支持市場的增長。 例如，2021 年 4 月，Welland Medical 通過其經銷商 Premier Ostomy Center 擴大了在加拿大的業務。 居住在加拿大的人可以直接使用。 預計此類新興市場的發展將在預測期內推動該國的市場增長。 此外，2022 年 1 月，Owens & Minor Inc .和 Apria Inc .簽訂了 Owens & Minor 收購 Apria 的最終協議。 此次收購預計將擴大公司的造口術產品組合。

失禁器械和造口術市場-IMG2

失禁器械和造口術行業概覽

失禁和造口護理市場競爭激烈，由許多主要參與者組成。 Abena AS、B. Braun Melsungen AG、Coloplast Corporation、ConvaTec、Hollister Inc. 和 Kimberly-Clark Corporation 等公司佔據了相當大的市場份額。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 世界失禁人數增加
    • 腎臟疾病和腎臟損傷的患病率增加
    • 對造口護理產品的認識和接受度不斷提高
  • 市場製約因素
    • 缺乏足夠的保險報銷
    • 與使用造口術和失禁產品相關的並發症
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品類型
    • 失禁護理產品
      • 吸收器
      • 失禁包
      • 其他產品類型（夾具、除臭劑、清潔劑、小便池等）
    • 造口護理產品
      • 造口袋
      • 結腸造口袋
      • 迴腸造口袋
      • 泌尿造口袋
      • 皮膚屏障
      • 灌溉產品
      • 其他結腸造口產品
  • 通過使用
    • 膀胱癌
    • 結腸癌
    • 克羅恩病
    • 腎結石
    • 慢性腎功能衰竭
    • 其他用途
  • 地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abena AS
    • B. Braun Melsungen AG
    • Coloplast Corporation
    • ConvaTec
    • Hollister Inc.
    • Kimberly-Clark Corporation
    • Salts Healthcare
    • Unicharm Corporation
    • Welland Medical
    • Pelican Healthcare Ltd.
    • Flexicare（Group）Limited
    • Torbot Group, Inc.

第七章市場機會與未來趨勢

簡介目錄
Product Code: 57125

The incontinence and ostomy care product market is expected to register a CAGR of nearly 10.1% during the forecast period.

The outbreak of the COVID-19 pandemic significantly impacted the incontinence devices and ostomy business, as only the most acute ostomy surgeries were performed following the outbreak. Stoma care is a potentially overlooked aspect of the outbreak, and no specific stoma care recommendations were published during the pandemic. According to the study published by the National Library of Medicine in March 2022, ostomies decreased by 19.5% during the time between March 2020 and February 2021. Thus, the decline in surgeries related to ostomies hampered the growth of the market during the pandemic. However, the demand for ostomy care products for home care considerably increased during the same period as most patients opted for home treatments. Hence, COVID-19 had a significant impact on market growth. However, as COVID-19 cases have subsided, the market has been recovering very well and is likely to maintain the same trend over the forecast period.

The major factor contributing to the growth of the market studied is the high prevalence of inflammatory bowel diseases (IBD), rising prevalence of urinary incontinence (UI), including ulcerative colitis or Crohn's disease, and colorectal cancer, resulting in increased ostomy surgery cases. According to the WHO updates from July 2021, an increase of around 70% is expected in colorectal cancer cases across the world by 2030. Furthermore, according to statistics published by GLOBOCAN, colorectal cancer (CRC) is the fourth most common type of cancer among the German population, and approximately 57,528 new cases of CRC were reported in Germany in 2021. Additionally, according to statistics provided by GLOBOCAN in 2020, approximately 33,815 new cases of colon cancer and 11,951 new deaths were reported in the United Kingdom in 2020 increasing the demand for ostomy surgeries and devices, thereby boosting the market growth over the forecast period. Moreover, as per a study published in April 2022 by Female Pelvic Medicine & Reconstructive Surgery, 61.8% of women had urinary incontinence (UI), corresponding to 78,297,094 adult United States women, with 32.4% of all women reporting symptoms at least monthly in 2021. Of those with UI, 37.5% had stress urinary incontinence, 22.0% had urgency urinary incontinence, 31.3% had mixed symptoms, and 9.2% had unspecified incontinence. Thus, a high burden of UI in women is expected to increase the demand for incontinence products which is expected to boost the growth of the market over the forecast period.

The development of efficient and suitable pouching systems and associated accessories which help to improve the quality of life of ostomy patients, is expected to open up the growth horizons for the studied market over the forecast period. For instance, the company Trio Healthcare launched a silicone-based ostomy seal, Trio Siltac. This product aids in preventing leakage and protecting the skin around the stoma. Such technological advancements are anticipated to propel the market growth over the forecast period.

Furthermore, an increase in initiatives to raise awareness about ostomy in individuals further propels the growth of the market. For instance, the United Ostomy Association of America Inc. (UOAA) works to improve the quality of ostomy healthcare and promote higher standards of care in all healthcare settings. The organization commemorates World Ostomy Day on the first Saturday of October every year to raise awareness about ostomy care. Such initiatives is likely to create awareness among the general population about stoma care, thereby aiding market growth.

However, lack of proper reimbursement and complications associated with ostomy and usage of incontinence products are likely to restrain the market growth.

Incontinence Devices and Ostomy Market Trends

Colostomy Bags are Expected to Observe Lucrative Growth in the Application Segment

A colostomy bag also called a stoma bag, or ostomy bag, is a small, waterproof pouch used to collect waste from the body. During a surgical procedure known as a colostomy, an opening, called a stoma or ostomy, is formed between the large intestine (colon) and the abdominal wall. This allows waste products to be excreted through the opening in the abdominal wall rather than via the colon through the rectum and anus. Stools and other waste products are drainable into the pouch-like colostomy bag, which can then be emptied at regular intervals.

The demand for these bags has increased over the years due to the increasing incidence of inflammatory bowel diseases (IBD). For instance, according to the research study published in BMC Journal in August 2021, in the United Kingdom, the incidence of inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) were found to be 28.6, 10.2, and 15.7 per 100,000 population, respectively in 2021. Such a high incidence of these diseases is expected to drive market growth.

Furthermore, the rising number of product launches is also expected to further drive segmental growth in the coming years. The introduction of efficient and suitable ostomy bags which help to improve the quality of life of ostomy patients is expected to provide ample growth opportunities for the segment's growth. For instance, in June 2021, Pelican Healthcare Ltd., located in Cardiff, strengthened its position as one of the leading manufacturers of disposable stoma devices in the United Kingdom and Ireland healthcare sectors with the introduction of the ModaViostomy bag range.

Incontinence Devices and Ostomy Market - IMG1

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America dominated the incontinence and ostomy care products market and accounted for the largest revenue share owing to factors such as an increase in the number of patients due to Crohn's disease, ulcerative colitis, and rising awareness initiatives related to ostomy care or stoma surgical procedures.

As per a Johns Hopkins University article of 2023, more than 25 million adult Americans experience temporary or chronic urinary incontinence. Additionally, the cost of treatment of UI in the United States alone is USD 16.3 billion, 75% of which is spent on the treatment of women. This increasing prevalence of UI in the United States is expected to propel the market's growth.

Moreover, several market players are implementing various strategic initiatives that support the market's growth. For instance, in April 2021, Welland Medical expanded its business in Canada through its distributor, Premier Ostomy Centre. It is directly available to people living in Canada. Such developments are likely to boost the market growth in the nation over the forecast period. Additionally, in January 2022, Owens & Minor Inc. and Apria Inc. entered into a definitive agreement under which Owens & Minor will acquire Apria. The acquisition is anticipated to broaden the company's ostomy portfolio.

Incontinence Devices and Ostomy Market - IMG2

Incontinence Devices and Ostomy Industry Overview

The incontinence devices and ostomy care products market is highly competitive and consists of a number of major players. Companies like Abena AS, B. Braun Melsungen AG, Coloplast Corporation, ConvaTec, Hollister Inc., and Kimberly-Clark Corporation, among others, hold substantial shares in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incontinence Around the World
    • 4.2.2 Increasing Prevalence of Renal Diseases and Nephrological Injuries
    • 4.2.3 Growing Awareness and Acceptance regarding Ostomy Care Products
  • 4.3 Market Restraints
    • 4.3.1 Lack of Proper Reimbursement
    • 4.3.2 Complications Associated with Ostomy and Usage of Incontinence Products
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Incontinence Care Products
      • 5.1.1.1 Absorbents
      • 5.1.1.2 Incontinence Bags
      • 5.1.1.3 Other Product Types (Clamps, Deodorizers, Cleaners, Urinals, etc.)
    • 5.1.2 Ostomy Care Products
      • 5.1.2.1 Ostomy Bags
      • 5.1.2.1.1 Colostomy Bags
      • 5.1.2.1.2 Ileostomy Bags
      • 5.1.2.1.3 Urostomy Bags
      • 5.1.2.2 Skin Barriers
      • 5.1.2.3 Irrigation Products
      • 5.1.2.4 Other Ostomy Products
  • 5.2 By Application
    • 5.2.1 Bladder Cancer
    • 5.2.2 Colorectal Cancer
    • 5.2.3 Crohn's Disease
    • 5.2.4 Kidney Stone
    • 5.2.5 Chronic Kidney Failure
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abena AS
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Coloplast Corporation
    • 6.1.4 ConvaTec
    • 6.1.5 Hollister Inc.
    • 6.1.6 Kimberly-Clark Corporation
    • 6.1.7 Salts Healthcare
    • 6.1.8 Unicharm Corporation
    • 6.1.9 Welland Medical
    • 6.1.10 Pelican Healthcare Ltd.
    • 6.1.11 Flexicare (Group) Limited
    • 6.1.12 Torbot Group, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS